The 36-month beta value for CC is also noteworthy at 1.99. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for CC is 147.02M, and at present, short sellers hold a 3.32% of that float. The average trading volume of CC on April 18, 2024 was 2.07M shares.
CC) stock’s latest price update
Chemours Company (NYSE: CC)’s stock price has gone decline by -0.15 in comparison to its previous close of 26.41, however, the company has experienced a -4.14% decrease in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-02 that From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
CC’s Market Performance
Chemours Company (CC) has experienced a -4.14% fall in stock performance for the past week, with a -5.14% drop in the past month, and a -8.53% drop in the past quarter. The volatility ratio for the week is 3.11%, and the volatility levels for the past 30 days are at 4.55% for CC. The simple moving average for the last 20 days is -3.95% for CC’s stock, with a simple moving average of -11.75% for the last 200 days.
Analysts’ Opinion of CC
Many brokerage firms have already submitted their reports for CC stocks, with BMO Capital Markets repeating the rating for CC by listing it as a “Outperform.” The predicted price for CC in the upcoming period, according to BMO Capital Markets is $34 based on the research report published on April 09, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see CC reach a price target of $21, previously predicting the price at $37. The rating they have provided for CC stocks is “Neutral” according to the report published on March 05th, 2024.
BMO Capital Markets gave a rating of “Underperform” to CC, setting the target price at $19 in the report published on February 29th of the current year.
CC Trading at -3.16% from the 50-Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.47% of loss for the given period.
Volatility was left at 4.55%, however, over the last 30 days, the volatility rate increased by 3.11%, as shares sank -3.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.78% lower at present.
During the last 5 trading sessions, CC fell by -4.14%, which changed the moving average for the period of 200-days by -28.52% in comparison to the 20-day moving average, which settled at $27.40. In addition, Chemours Company saw -16.39% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CC starting from Newman Mark, who purchase 7,661 shares at the price of $34.63 back on Jun 09 ’23. After this action, Newman Mark now owns 266,955 shares of Chemours Company, valued at $265,300 using the latest closing price.
Scarborough Alvenia, the SVP Corp Communications & CBO of Chemours Company, sale 5,125 shares at $32.30 during a trade that took place back on Jun 09 ’23, which means that Scarborough Alvenia is holding 13,890 shares at $165,537 based on the most recent closing price.
Stock Fundamentals for CC
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.22 for the gross margin
The net margin for Chemours Company stands at -0.04. The total capital return value is set at -0.01. Equity return is now at value -25.70, with -2.98 for asset returns.
Based on Chemours Company (CC), the company’s capital structure generated 0.85 points at debt to capital in total, while cash flow to debt ratio is standing at 0.14. The debt to equity ratio resting at 5.49. The interest coverage ratio of the stock is -0.85.
Currently, EBITDA for the company is 220.0 million with net debt to EBITDA at 15.67. When we switch over and look at the enterprise to sales, we see a ratio of 1.06. The receivables turnover for the company is 9.88for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.54.
Conclusion
In summary, Chemours Company (CC) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
